Robert T. Fraley is a prominent figure in agricultural biotechnology, widely recognized for his leadership role at Monsanto and contributions to genetically modified crops. Estimates of his net worth reflect decades of innovation, executive compensation, and ongoing influence within the agritech sector.
This article examines key dimensions of his financial and professional profile, offering a structured overview of career milestones, earnings drivers, and industry impact. The following sections provide context for understanding how his work shaped the modern seed and crop protection markets.
| Category | Detail | Value / Notes | Source Context |
|---|---|---|---|
| Name | Robert T. Fraley | Executive Vice President and Chief Technology Officer | Monsanto leadership record |
| Primary Role | Technology and R&D Leader | Directed commercialization of biotech traits | Corporate bio and public filings |
| Key Company | Monsanto | Acquired by Bayer | Major agribusiness employer |
| Industry Focus | Seeds and Crop Protection | Herbicide-tolerant and insect-resistant crops | Product portfolio impact |
| Reported Net Worth Range | Estimates vary widely | $60 million to over $200 million | Public records and compensation data |
Early Career And Technical Contributions
Fraley spent much of his career at Monsanto, where he led research in plant biotechnology and trait development. His work focused on genetic engineering for herbicide tolerance and insect resistance, key drivers of the company's seed business growth.
These innovations generated substantial licensing and product revenue, influencing both company valuation and executive pay packages. As a result, his compensation likely included a combination of salary, bonuses, stock awards, and long-term incentive payouts.
Executive Compensation Structure
At Monsanto, executive pay was typically tied to corporate performance metrics, including sales growth in core crop segments and successful product launches. Stock-based awards formed a significant portion of total compensation over the long term.
Share price appreciation and dividend policies would have directly affected the realized value of his equity holdings. Understanding this structure helps explain how reported earnings and market conditions shaped his net worth over time.
Role In Agricultural Innovation
Product Development Impact
Fraley's leadership supported the rollout of major biotech traits that reduced weed competition and insect damage. These products generated strong demand from farmers, bolstering revenue streams and profit margins for Monsanto.
Market Position And Licensing
By advancing trait pipelines, he contributed to Monsanto's dominant position in key seed markets. Global licensing agreements and technology fees further increased the company's earnings, with executive compensation packages reflecting these successes.
Post-Monsanto And Current Activities
After Bayer completed its acquisition of Monsanto, Fraley continued in executive and advisory roles within the combined entity. Changes in company structure and long-term incentive vesting likely influenced the valuation of his remaining holdings.
Ongoing involvement in industry initiatives and advisory boards may provide additional income and equity stakes, affecting updates to his estimated net worth.
Key Takeaways And Recommendations
- Review SEC filings and proxy statements for detailed breakdowns of executive compensation components.
- Track stock performance and vesting schedules to understand how equity awards contribute to net worth.
- Consider the long-term value of roles in both standalone and merged organizations like Bayer.
- Factor in advisory and board positions when assessing current earnings and asset holdings.
FAQ
Reader questions
How is Robert T. Fraley's net worth estimated in publicly available sources?
Estimates typically combine reported executive compensation, historical stock awards, options exercised, and current holdings disclosed in regulatory filings. Public records and media reports synthesize these inputs to form a range rather than a precise figure.
What portion of his net worth comes from stock awards and equity grants?
A substantial share is derived from long-term stock incentives tied to company performance and tenure. As Monsanto's share price appreciated, the value of these awards increased significantly.
Does his involvement in advisory roles after retirement affect net worth estimates?
Advisory board positions and consultancy agreements can add both cash compensation and equity components. These ongoing arrangements are factored into updated net worth assessments where details are available.
Why do estimates for Robert T. Fraley's net worth vary so widely?
Variations arise from differences in available data, assumptions about unvested equity, and the inclusion or exclusion of personal investments. Some estimates also incorporate real estate and other assets that are not publicly confirmed.